http://www.unboundmedicine.com/medline/ebm/research/adalimumabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19889301/full_citation/Efficiency_of_Biologic_Agents_in_the_Treatment_of_Moderate_to_Severe_Psoriasis_Blasco AJ, Lázaro P, Ferrándiz C, et al. 
Efficiency of Biologic Agents in the Treatment of Moderate to Severe Psoriasis. [JOURNAL ARTICLE]
Actas Dermosifiliogr 2009 Nov; 100(9):792-803.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886983/full_citation/ACR70_disease_activity_score_remission_achievement_from_switches_between_all_the_available_biological_agents_in_rheumatoid_arthritis:_a_systematic_review_of_the_literature_Alivernini S, Laria A, Gremese E, et al. 
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature. [JOURNAL ARTICLE]
Arthritis Res Ther 2009 Nov 3; 11(6):R163.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19885906/full_citation/Safety_of_immunomodulators_and_biologics_for_the_treatment_of_inflammatory_bowel_disease_during_pregnancy_and_breast_feeding_Gisbert JP 
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884297/full_citation/A_network_meta_analysis_of_randomized_controlled_trials_of_biologics_for_rheumatoid_arthritis:_a_Cochrane_overview_Singh JA, Christensen R, Wells GA, et al. 
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. [JOURNAL ARTICLE]
CMAJ 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884029/full_citation/[Quality_of_storage_of_thermolabile_drugs_in_patients'_homes_]Cuéllar MJ, Marco JL, Pérez-Castelló I, et al. 
[Quality of storage of thermolabile drugs in patients' homes.] [JOURNAL ARTICLE]
Rev Calid Asist 2009 Oct 31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19880688/full_citation/Lupus_like_syndrome_attributable_to_anti_tumor_necrosis_factor_alpha_therapy_in_14_patients_during_an_8_year_period_at_Mayo_Clinic_Wetter DA, Davis MD 
Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. [Journal Article]
Mayo Clin Proc 2009 Nov; 84(11):979-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877027/full_citation/Cancer_risk_in_patients_with_rheumatoid_arthritis_treated_with_anti_tumor_necrosis_factor_alpha_therapies:_Does_the_risk_change_with_the_time_since_start_of_treatmentAskling J, van Vollenhoven RF, Granath F, et al. 
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment? [JOURNAL ARTICLE]
Arthritis Rheum 2009 Oct 29; 60(11):3180-3189.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19875411/full_citation/Severe_cardiomyopathy_following_treatment_with_the_tumour_necrosis_factor_alpha_inhibitor_adalimumab_for_Crohn's_disease_Emmert MY, Salzberg SP, Emmert LS, et al. 
Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease. [Journal Article]
Eur J Heart Fail 2009 Nov; 11(11):1106-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19874430/full_citation/An_Italian_shared_dermatological_and_rheumatological_proposal_for_the_use_of_biological_agents_in_psoriatic_disease_Marchesoni A, Altomare G, Matucci-Cerinic M, et al. 
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Oct 23.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19863499/full_citation/Antinuclear_antibodies_associate_with_loss_of_response_to_anti_TNF_alpha_therapy_in_psoriasis___a_retrospective_observational_study_Pink AE, Fonia A, Allen MH, et al. 
Antinuclear antibodies associate with loss of response to anti-TNF alpha therapy in psoriasis - a retrospective, observational study. [JOURNAL ARTICLE]
Br J Dermatol 2009 Oct 26.
Abstract | Full Citation | Find Related Articles